These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38150605)

  • 1. The mediator role of treatment response on oral health related quality of life in Behçet's syndrome.
    Altıngöz EN; Yenisoy Y; Kapusuz A; Abacar K; Şişman-Kitapçı N; Yay M; Karacaylı U; Alibaz-Öner F; İnanç N; Ergun T; Fortune F; Direskeneli H
    Med Oral Patol Oral Cir Bucal; 2024 May; 29(3):e350-e355. PubMed ID: 38150605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for the management of oral ulcers in Behçet's disease.
    Taylor J; Glenny AM; Walsh T; Brocklehurst P; Riley P; Gorodkin R; Pemberton MN
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD011018. PubMed ID: 25254615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of apremilast for the treatment of adult patients with oral ulcers associated with Behçet's syndrome.
    Özdede A; Hatemi G
    Expert Opin Pharmacother; 2021 Aug; 22(12):1533-1537. PubMed ID: 34218739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?
    Çandereli ZÖ; Arslan T; Özdamar Ö; Yay M; Karaçayli Ü; Şişman-Kitapçi N; Adesanya A; Aksoy A; Belem JMFM; Taş MN; Cardin NB; Sacoor S; Gokani B; Armağan B; Sari A; Bozca BC; Tekgöz E; Desai P; Temiz Karadağ D; Badak SÖ; Tecer D; Bibi A; Yildirim A; Bes C; Şahin A; Erken E; Cefle A; Çinar M; Yilmaz S; Alpsoy E; Boyvat A; Şenel S; Yaşar Bilge Ş; Kaşifoğlu T; Karadağ Ö; Aksu K; Keser G; Alibaz-Öner F; Inanç N; Ergun T; Madanat W; de Souza AWS; Direskeneli H; Fortune F; Mumcu G
    Clin Exp Rheumatol; 2023 Oct; 41(10):2078-2086. PubMed ID: 37902270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
    Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
    N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status.
    Senusi AA; Ola D; Mather J; Mather J; Fortune F
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):43-50. PubMed ID: 28598773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of minimal clinically important improvement by using Oral Health Impact Profile-14 in Behçet's disease.
    Hayran O; Mumcu G; Inanc N; Ergun T; Direskeneli H
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S79-84. PubMed ID: 19796539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Patients' Beliefs Regarding the Role of Food, Mucosal Trauma, Menstruation, and Psychological Stress in the Recurrence of Behçet's Disease Symptoms.
    Shenavandeh S; Asis M; Eftekhari MH; Aflaki E; Abdollahifard GR; Abnavi MA; Ahmadi A
    J Med Life; 2020; 13(2):164-169. PubMed ID: 32742508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome.
    Hamuryudan V; Hatemi G; Sut N; Ugurlu S; Yurdakul S; Yazici H
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S32-4. PubMed ID: 22935508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of oral health and psycho-social well-being on clinical outcomes in Behçet's disease.
    Senusi A; Higgins S; Fortune F
    Rheumatol Int; 2018 Oct; 38(10):1873-1883. PubMed ID: 30151720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
    Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
    Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderation analysis exploring associations between age and mucocutaneous activity in Behçet's syndrome: A multicenter study from Turkey.
    Mumcu G; Yay M; Karaçaylı Ü; Aksoy A; Taş MN; Armağan B; Sarı A; Bozca BC; Tekgöz E; Temiz Karadağ D; Badak SÖ; Tecer D; Yıldırım A; Bes C; Şahin A; Erken E; Cefle A; Çınar M; Yılmaz S; Alpsoy E; Boyvat A; Şenel S; Bilge ŞY; Kaşifoğlu T; Karadağ Ö; Aksu K; Keser G; Alibaz-Öner F; İnanç N; Ergun T; Direskeneli H
    J Dermatol; 2020 Dec; 47(12):1403-1410. PubMed ID: 32981075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of presenteeism and activity impairment in Behçet's syndrome and recurrent aphthous stomatitis: a multicentre study.
    Karacayli U; Adesanya A; Aksoy A; Belem JMFM; Cardin NB; Sarı FB; Beyhan TE; Çelik Z; Karacayli C; Alibaz-Öner F; Inanç N; Ergun T; Yay M; Madanat W; Silva de Souza AW; Fortune F; Direskeneli H; Mumcu G
    Rheumatology (Oxford); 2022 Apr; 61(4):1538-1547. PubMed ID: 34289015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicidal ideation among patients with Behçet's syndrome.
    Saygin C; Uzunaslan D; Hatemi G; Hamuryudan V
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S30-5. PubMed ID: 25797433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mouthwash: an efficacious intervention for oral ulceration associated with Behçet's disease.
    Senusi A; Kang A; Buchanan JAG; Adesanya A; Aloraini G; Stanford M; Fortune F
    Br J Oral Maxillofac Surg; 2020 Oct; 58(8):1034-1039. PubMed ID: 32819746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease.
    Mumcu G; Niazi S; Stewart J; Hagi-Pavli E; Gokani B; Seoudi N; Ergun T; Yavuz S; Stanford M; Fortune F; Direskeneli H
    J Oral Pathol Med; 2009 May; 38(5):406-9. PubMed ID: 19298505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue is correlated with disease activity but not with the type of organ involvement in Behçet's syndrome: a comparative clinical survey.
    Buyuktas D; Hatemi G; Yuksel-Findikoglu S; Ugurlu S; Yazici H; Yurdakul S
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S107-12. PubMed ID: 26487169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
    Hatemi G; Mahr A; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35798511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral health related quality of life is affected by disease activity in Behçet's disease.
    Mumcu G; Inanc N; Ergun T; Ikiz K; Gunes M; Islek U; Yavuz S; Sur H; Atalay T; Direskeneli H
    Oral Dis; 2006 Mar; 12(2):145-51. PubMed ID: 16476035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
    De Luca G; Cariddi A; Campochiaro C; Vanni D; Boffini N; Tomelleri A; Cavalli G; Dagna L
    Rheumatology (Oxford); 2020 Jan; 59(1):171-175. PubMed ID: 31280296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.